ZTO Express Announces Further ADS Buy-Back; 2.48 Million Shares Repurchased Since Mid-June Mandate

Bulletin Express07-02

ZTO Express (Cayman) Inc. reported no change in its issued share capital as of 1 July 2026, maintaining 563.80 million Class A ordinary shares outstanding (total issued share count: 769.90 million shares, including Class B shares).

On 1 July 2026 (U.S. time) the company repurchased 217,777 American Depositary Shares—each representing one Class A ordinary share—on the New York Stock Exchange at prices ranging from USD 22.69 to USD 23.00, for a total consideration of USD 5.00 million.

Highlights of the current buy-back programme:

• Board mandate: Approved on 16 June 2026 for up to 76.60 million shares. • Cumulative repurchases under this mandate (16 June–1 July 2026): 2.48 million ADS, equivalent to 0.32 % of issued shares as at the mandate date. • Aggregate repurchase cost on 1 July transaction: USD 4.99 million. • Aggregate ADS awaiting formal cancellation (20 May–1 July 2026): 6.38 million shares, including the latest purchase. • Moratorium: The company is restricted from issuing new shares or transferring treasury shares until 31 July 2026.

All repurchases were executed in compliance with the Hong Kong Stock Exchange Main Board Rules and the applicable regulations of the New York Stock Exchange.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment